# Mesoblast (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/mesoblast-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 66.5 |
| Citations | 10,436 |
| City | New York |
| Country | US |
| Description | Mesoblast (United States) is a research organisation in New York, US. OpenAlex records 58 works and 10,436 citations for it. |
| Homepage | https://www.mesoblast.com/ |
| OpenAlex ID | https://openalex.org/I4210120087 |
| Region | New York |
| ROR ID | https://ror.org/029c3g514 |
| Type | company |
| Works | 58 |

## University papers

- [Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects](https://scholariq.org/papers/hematopoietic-cell-transplantation-in-older-patients-with-hematologic/)
- [Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma](https://scholariq.org/papers/myeloablative-autologous-stem-cell-transplantation-for-severe-scleroderma/)
- [Implantable Left Ventricular Assist Devices](https://scholariq.org/papers/implantable-left-ventricular-assist-devices/)
- [Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical Unloading](https://scholariq.org/papers/reversal-of-chronic-ventricular-dilation-in-patients-with-end-stage/)
- [Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies](https://scholariq.org/papers/long-term-outcomes-among-older-patients-following-nonmyeloablative-conditioning/)
- [Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease](https://scholariq.org/papers/phase-i-ii-trial-of-autologous-stem-cell-transplantation-in-systemic-sclerosis/)
- [High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis](https://scholariq.org/papers/high-dose-immunosuppressive-therapy-and-autologous-peripheral-blood-stem-cell/)
- [Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma](https://scholariq.org/papers/prophylactic-corticosteroid-use-in-patients-receiving-axicabtagene-ciloleucel/)
- [Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation](https://scholariq.org/papers/graft-versus-host-disease-and-graft-versus-tumor-effects-after-allogeneic/)

## University top topics

Showing 8 of 25.

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Spine and Intervertebral Disc Pathology](https://scholariq.org/topics/spine-and-intervertebral-disc-pathology/)
- [Pluripotent Stem Cells Research](https://scholariq.org/topics/pluripotent-stem-cells-research/)
- [Tissue Engineering and Regenerative Medicine](https://scholariq.org/topics/tissue-engineering-and-regenerative-medicine/)
- [Musculoskeletal pain and rehabilitation](https://scholariq.org/topics/musculoskeletal-pain-and-rehabilitation/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.